{"id":5645,"date":"2007-07-06T07:42:00","date_gmt":"2007-07-06T07:42:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5645"},"modified":"2021-07-09T11:16:15","modified_gmt":"2021-07-09T11:16:15","slug":"a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/","title":{"rendered":"A Case Report of Steroid and Immunosuppressant-resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Okuma+K&amp;cauthor_id=17845399\">Keiko Okuma<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17845399\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mitsuishi+K&amp;cauthor_id=17845399\">Kouichi Mitsuishi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hasegawa+T&amp;cauthor_id=17845399\">Toshio Hasegawa<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tsuchihashi+H&amp;cauthor_id=17845399\">Hitoshi Tsuchihashi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ogawa+H&amp;cauthor_id=17845399\">Hideoki Ogawa<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ikeda+S&amp;cauthor_id=17845399\">Shigaku Ikeda<\/a>, Ther Apher Dial. 2007 Oct;11(5):387-90.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>&nbsp;Our results suggest that GCAP is a safe and useful tool for the treatment of intractable PG, and that IL-8 and G-CSF are likely to be involved in the pathogenesis of PG.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17845399\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/17845399\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Keiko Okuma&nbsp;1,&nbsp;Kouichi Mitsuishi,&nbsp;Toshio Hasegawa,&nbsp;Hitoshi Tsuchihashi,&nbsp;Hideoki Ogawa,&nbsp;Shigaku Ikeda, Ther Apher Dial. 2007 Oct;11(5):387-90. &nbsp;Our results suggest that GCAP is a safe and useful tool for the treatment of intractable PG, and that IL-8 and G-CSF are likely to be involved in the pathogenesis of PG. https:\/\/pubmed.ncbi.nlm.nih.gov\/17845399\/<\/p>\n","protected":false},"template":"","scientific_tags":[307,135],"class_list":["post-5645","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-dermatology","scientific_tags-steroid-refractory"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>A Case Report of Steroid and Immunosuppressant-resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Case Report of Steroid and Immunosuppressant-resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Keiko Okuma&nbsp;1,&nbsp;Kouichi Mitsuishi,&nbsp;Toshio Hasegawa,&nbsp;Hitoshi Tsuchihashi,&nbsp;Hideoki Ogawa,&nbsp;Shigaku Ikeda, Ther Apher Dial. 2007 Oct;11(5):387-90. &nbsp;Our results suggest that GCAP is a safe and useful tool for the treatment of intractable PG, and that IL-8 and G-CSF are likely to be involved in the pathogenesis of PG. https:\/\/pubmed.ncbi.nlm.nih.gov\/17845399\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:16:15+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/\",\"name\":\"A Case Report of Steroid and Immunosuppressant-resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2007-07-06T07:42:00+00:00\",\"dateModified\":\"2021-07-09T11:16:15+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Case Report of Steroid and Immunosuppressant-resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/","og_locale":"fr_FR","og_type":"article","og_title":"A Case Report of Steroid and Immunosuppressant-resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis - Adacyte","og_description":"Keiko Okuma&nbsp;1,&nbsp;Kouichi Mitsuishi,&nbsp;Toshio Hasegawa,&nbsp;Hitoshi Tsuchihashi,&nbsp;Hideoki Ogawa,&nbsp;Shigaku Ikeda, Ther Apher Dial. 2007 Oct;11(5):387-90. &nbsp;Our results suggest that GCAP is a safe and useful tool for the treatment of intractable PG, and that IL-8 and G-CSF are likely to be involved in the pathogenesis of PG. https:\/\/pubmed.ncbi.nlm.nih.gov\/17845399\/","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:16:15+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/","name":"A Case Report of Steroid and Immunosuppressant-resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2007-07-06T07:42:00+00:00","dateModified":"2021-07-09T11:16:15+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-case-report-of-steroid-and-immunosuppressant-resistant-pyoderma-gangrenosum-successfully-treated-by-granulocytapheresis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/5645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5645"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=5645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}